Sign up to save your podcasts
Or
Share Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model
Date: 6/5/2008 Length: 00:06:39 Size: 3.04MB Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
View all episodes
By Daniel LimbachDate: 6/5/2008 Length: 00:06:39 Size: 3.04MB Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.